Page last updated: 2024-10-22

acetazolamide and Ischemic Stroke

acetazolamide has been researched along with Ischemic Stroke in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.

Research Excerpts

ExcerptRelevanceReference
"We want to investigate the effect of aquaporin-4 (AQP4) on cerebral edema induced by ischemic stroke in rats and explore whether inhibiting the expression of AQP4 through acetazolamide (AZA) could attenuate brain edema and protect cerebral function."8.12Acetazolamide Alleviate Cerebral Edema Induced by Ischemic Stroke Through Inhibiting the Expression of AQP4 mRNA. ( Bai, H; Duan, HB; Duan, SQ; Hao, CY; Hao, JQ; He, XY; Shi, JY; Wang, H; Wang, ZZ; Xiao, YC; Yang, X; Zhang, Y; Zhu, XL, 2022)
"We want to investigate the effect of aquaporin-4 (AQP4) on cerebral edema induced by ischemic stroke in rats and explore whether inhibiting the expression of AQP4 through acetazolamide (AZA) could attenuate brain edema and protect cerebral function."4.12Acetazolamide Alleviate Cerebral Edema Induced by Ischemic Stroke Through Inhibiting the Expression of AQP4 mRNA. ( Bai, H; Duan, HB; Duan, SQ; Hao, CY; Hao, JQ; He, XY; Shi, JY; Wang, H; Wang, ZZ; Xiao, YC; Yang, X; Zhang, Y; Zhu, XL, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Nemoto, EM2
Yonas, H2
Hao, JQ1
He, XY1
Yang, X1
Xiao, YC1
Duan, SQ1
Wang, H1
Bai, H1
Zhang, Y1
Shi, JY1
Zhu, XL1
Wang, ZZ1
Hao, CY1
Duan, HB1

Other Studies

2 other studies available for acetazolamide and Ischemic Stroke

ArticleYear
Cerebrovascular Reserve (CVR) and Stages of Hemodynamic Compromise.
    Advances in experimental medicine and biology, 2022, Volume: 1395

    Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Hemodynamics; Humans; Ischemic Stroke; Oxygen; Po

2022
Cerebrovascular Reserve (CVR) and Stages of Hemodynamic Compromise.
    Advances in experimental medicine and biology, 2022, Volume: 1395

    Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Hemodynamics; Humans; Ischemic Stroke; Oxygen; Po

2022
Cerebrovascular Reserve (CVR) and Stages of Hemodynamic Compromise.
    Advances in experimental medicine and biology, 2022, Volume: 1395

    Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Hemodynamics; Humans; Ischemic Stroke; Oxygen; Po

2022
Cerebrovascular Reserve (CVR) and Stages of Hemodynamic Compromise.
    Advances in experimental medicine and biology, 2022, Volume: 1395

    Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Hemodynamics; Humans; Ischemic Stroke; Oxygen; Po

2022
Acetazolamide Alleviate Cerebral Edema Induced by Ischemic Stroke Through Inhibiting the Expression of AQP4 mRNA.
    Neurocritical care, 2022, Volume: 36, Issue:1

    Topics: Acetazolamide; Animals; Aquaporin 4; Brain Edema; Ischemic Stroke; Rats; Rats, Sprague-Dawley; RNA,

2022